EVP, Chief Financial Officer
Sun, Mar 3, 2024
Mar 3
exercised or converted securities in TEVA
49,800 shares @ $0.00
Increased holdings by +40.10%
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
Health CarePharmaceuticals
1D0.00%
1W+0.96%
1M+19.47%
3M+6.36%
6M—
1Y—